- Monday (3/12): Cowen (continued): AVEO Oncology (NASDAQ:AVEO); Acorda Therapeutics (NASDAQ:ACOR); Merus N.V. (NASDAQ:MRUS); Sunesis Pharmaceuticals (NASDAQ:SNSS); Foamix Pharmaceuticals (NASDAQ:FOMX); MyoKardia (NASDAQ:MYOK); Albireo Pharma (NASDAQ:ALBO); Ophthotech (NASDAQ:OPHT); Calithera Biosciences (NASDAQ:CALA); Achaogen (NASDAQ:AKAO); Otonomy (NASDAQ:OTIC); Radius Health (NASDAQ:RDUS); Pieris Pharmaceuticals (NASDAQ:PIRS); ChemoCentryx (NASDAQ:CCXI); BioMarin Pharmaceutical (NASDAQ:BMRN); Akcea Therapeutics (NASDAQ:AKCA); ACADIA Pharmaceuticals (NASDAQ:ACAD); Sienna Biopharmaceuticals (NASDAQ:SNNA); Kura Oncology (OTCQB:KURO); Alnylam Pharmaceuticals (NASDAQ:ALNY); Puma Biotechnology (NYSE:PBYI); Portola Pharmaceuticals (NASDAQ:PTLA); Jazz Pharmaceuticals (NASDAQ:JAZZ); Five Prime Therapeutics (NASDAQ:FPRX); Atara Biotherapeutics (NASDAQ:ATRA); Supernus Pharmaceuticals (NASDAQ:SUPN); Proteon Therapeutics (NASDAQ:PRTO); Vanda Pharmaceuticals (NASDAQ:VNDA); TherapeuticsMD (NYSEMKT:TXMD); REVA Medical (OTC:RVALL); United Therapeutics (NASDAQ:UTHR); Proteostasis Therapeutics (NYSE:PTI); Ra Pharmaceuticals (NASDAQ:RARX); Spectrum Pharmaceuticals (NASDAQ:SPPI); Alexion Pharmaceuticals (NASDAQ:ALXN); Innovate Biopharmaceuticals (NASDAQ:INNT); Allena Pharmaceuticals (NASDAQ:ALNA); GlycoMimetics (NASDAQ:GLYC); Chimerix (NASDAQ:CMRX); Nektar Therapeutics (NASDAQ:NKTR); Aimmune Therapeutics (NASDAQ:AIMT); UroGen (NASDAQ:URGN); Catalyst Biosciences (NASDAQ:CBIO); Insmed (NASDAQ:INSM); Aerie Pharmaceuticals (NASDAQ:AERI); bluebird bio (NASDAQ:BLUE); Iovance Biotherapeutics (NASDAQ:IOVA); Neurocrine Biosciences (NASDAQ:NBIX).
- BIO CEO & Investor Conference, NYC (2 days). Checkpoint Therapeutics (OTCQX:CKPT).
- Now read: Ad Com Wednesday for expanded use of Amgen (NASDAQ:AMGN)'s Blincyto
Original article